NasdaqCM - Delayed Quote USD

Mereo BioPharma Group plc (MREO)

Compare
3.5500
-0.2100
(-5.59%)
At close: January 10 at 4:00:02 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
66,499.0000
77,413.0000
170,617.0540
85,785.7367
Total Liabilities Net Minority Interest
15,962.0000
26,011.0000
51,846.3033
106,188.5877
Total Equity Gross Minority Interest
50,537.0000
51,402.0000
118,770.7507
-20,402.8510
Total Capitalization
54,931.0000
51,402.0000
138,183.9285
1,595.8679
Common Stock Equity
50,537.0000
51,402.0000
118,770.7507
-20,402.8510
Capital Lease Obligations
1,558.0000
2,043.0000
3,206.7374
2,444.9078
Net Tangible Assets
49,448.0000
51,402.0000
85,618.2687
-63,533.5323
Working Capital
54,274.0000
50,822.0000
117,124.1936
28,838.7369
Invested Capital
54,931.0000
64,728.0000
138,183.9285
1,595.8679
Tangible Book Value
49,448.0000
51,402.0000
85,618.2687
-63,533.5323
Total Debt
5,952.0000
15,369.0000
22,619.9152
24,443.6267
Share Issued
701,217.0890
624,928.5190
584,908.2390
338,953.1410
Ordinary Shares Number
700,293.6890
623,925.4890
583,826.9840
337,715.8610
Treasury Shares Number
923.4000
1,003.0300
1,081.2550
1,237.2800
12/31/2020 - 4/24/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers